Daily Cosmetic Research Analysis
Safety-focused guidance on ultrasound-assisted hyaluronic acid filler injections in the Asian upper face, a mechanistic discovery linking lncRNA LINC00525 to TGF-β/Smad signaling in hypertrophic scar fibroblasts, and a hidden-scar retroauricular approach for cervical vagal schwannomas emerged as today’s most impactful work. Together, they advance procedural safety, scar biology, and aesthetic outcomes in head and neck surgery.
Summary
Safety-focused guidance on ultrasound-assisted hyaluronic acid filler injections in the Asian upper face, a mechanistic discovery linking lncRNA LINC00525 to TGF-β/Smad signaling in hypertrophic scar fibroblasts, and a hidden-scar retroauricular approach for cervical vagal schwannomas emerged as today’s most impactful work. Together, they advance procedural safety, scar biology, and aesthetic outcomes in head and neck surgery.
Research Themes
- Ultrasound-guided facial filler safety and anatomy
- lncRNA–TGF-β signaling in scar pathophysiology
- Hidden-scar approaches in head and neck surgery
Selected Articles
1. Recommendations on Ultrasound-Guided Hyaluronic Acid Soft Tissue Augmentation of the Upper Face in Asians.
Multinational experts synthesized ultrasound-based recommendations for safe HA filler injections in the Asian upper face, detailing vascular landmarks and technique adaptations for the forehead, temple, and upper eyelid. The guidance positions ultrasound as an adjunct to prevent and manage vascular adverse events.
Impact: This consensus provides actionable, anatomy-grounded guidance for a complication-prone aesthetic region, likely influencing training and routine practice.
Clinical Implications: Adopt pre-injection ultrasound mapping and real-time guidance in the forehead, temple, and periorbital regions to reduce vascular injury; incorporate ultrasound into protocols for early detection and management of filler-related adverse events.
Key Findings
- Defines ultrasound landmarks and safe planes for HA filler in forehead, temple, and upper eyelid.
- Recommends ultrasound as an adjunct to mitigate vascular variability and reduce ischemic events.
- Provides indication-specific technique tips tailored to Asian facial anatomy.
Methodological Strengths
- Multinational expert consensus integrating live model and cadaveric anatomical correlation.
- Focus on high-risk vascular territories with actionable technique standardization.
Limitations
- Consensus-based guidance without prospective clinical outcome validation.
- Focused on Asian anatomy; generalizability to other populations may be limited.
Future Directions: Prospective studies comparing ultrasound-guided versus landmark-only injections on vascular event rates; development of ultrasound training curricula and competency benchmarks.
BACKGROUND: Ultrasonography allows real-time imaging of facial soft tissue during hyaluronic acid (HA) filler injections. However, there is currently limited guidance relating to ultrasound-guided HA filler placement in the upper face. AIMS: To develop guidance for the effective use of ultrasonography to improve the safety of HA filler injection procedures. METHODS: Through a series of online video conferences and anatomical studies conducted on a model and a cadaveric specimen, specialists from Korea, Thailand, and China drew recommendations for ultrasound-guided filler injections of the upper face. RESULTS: The authors outlined critical anatomical landmarks for safe HA filler placement to correct volume deficits or treat hollowness of the forehead, temple, and upper eyelids. They provide insights on treatment indications and injection techniques using ultrasound for safe HA filler placement. The recommendations are presented in this paper. CONCLUSIONS: Where there are anatomic variations in the vasculature of the forehead, temple, and periorbital area, ultrasound-guided filler placement can provide an additional safety measure. Current evidence may give rise to standard practices incorporating ultrasound in injection protocols for the preventive and therapeutic management of adverse events.
2. LINC00525 promotes cell proliferation and collagen expression through feedforward regulation of TGF-β signaling in hypertrophic scar fibroblasts.
Using gain- and loss-of-function approaches, the authors show that lncRNA LINC00525 promotes fibroblast proliferation and collagen production in hypertrophic scarring by sponging miR-29a-5p, thereby sustaining TGF-β/Smad signaling in a feedforward loop. TGF-β1 upregulates LINC00525, reinforcing this pro-fibrotic circuit.
Impact: Identifies a previously uncharacterized lncRNA-driven feedforward mechanism linking miR-29a-5p and TGF-β/Smad signaling in scar fibroblasts, opening avenues for anti-scarring therapeutics.
Clinical Implications: While preclinical, targeting LINC00525 or restoring miR-29a-5p could modulate TGF-β signaling and collagen deposition, informing future anti-scarring pharmacotherapies or gene-based interventions.
Key Findings
- LINC00525 overexpression increases fibroblast proliferation and collagen expression; knockdown reduces them.
- LINC00525 interacts with miR-29a-5p; its downregulation elevates miR-29a-5p and suppresses TGF-β/Smad signaling.
- TGF-β1 upregulates LINC00525, forming a feedforward loop that sustains pro-fibrotic signaling.
Methodological Strengths
- Convergent evidence from knockdown/overexpression, subcellular localization, RNA pull-down, and PCR validation.
- Mechanistic linkage integrating lncRNA, microRNA, and TGF-β/Smad signaling.
Limitations
- Preclinical in vitro study; lacks in vivo validation in animal scar models.
- No assessment of off-target effects or safety of potential LINC00525/miR-29a-5p modulation.
Future Directions: Validate the LINC00525–miR-29a-5p–TGF-β axis in in vivo scar models and assess therapeutic modulation via antisense oligonucleotides or miRNA mimics.
The etiology of hypertrophic scar formation continues to elude researchers, despite advancements in the understanding of skin scarring. Several long non-coding RNAs (lncRNAs) have been implicated in the pathogenesis of hypertrophic scars, yet the role and molecular mechanisms of LINC00525 in this process remain unclear. This study demonstrates that LINC00525 enhances cell proliferation and collagen expression through knockdown and overexpression techniques. Further analysis, including nuclear and cytoplasmic localization studies, RNA pull-down assays, bioinformatics predictions, and PCR validation, reveals that LINC00525 interacts with miR-29a-5p. The downregulation of LINC00525 enhances the expression of miR-29a-5p and suppresses the TGF-β/Smad signaling pathway. Additionally, TGF-β1 induces the upregulation of LINC00525. Collectively, these findings indicate that LINC00525 operates through a feedforward mechanism to regulate TGF-β signaling in hypertrophic scar fibroblasts. This research offers novel insights for the prevention and treatment of scars.
3. Postauricular Approach for Enucleation of Cervical Vagal Schwannomas.
In 11 patients, a retroauricular hairline incision enabled intracapsular enucleation of cervical vagal schwannomas with minimal morbidity, excellent hidden-scar cosmetic outcomes, preserved swallowing, and no recurrences over a median 79 months.
Impact: Introduces a cosmetically favorable, function-preserving approach with durable oncologic control for a challenging cervical tumor.
Clinical Implications: Consider RAHI-based enucleation to optimize scar concealment and patient satisfaction while maintaining nerve function; counsel about transient vocal cord paresis and sensory changes.
Key Findings
- RAHI enabled safe intracapsular enucleation with median operative time 42 minutes and minimal bleeding.
- High cosmetic satisfaction (median VAS 9 for scar, 10 for facial contour) with hidden postauricular scars.
- Transient complications (earlobe numbness 45%, temporary vocal cord paralysis 27%) resolved within 1 year; no recurrences at median 79 months.
Methodological Strengths
- Long median follow-up (79 months) with comprehensive functional and cosmetic assessments.
- Consistent surgical approach across cases enabling reproducible evaluation.
Limitations
- Small, single-center case series without a comparative control group.
- Selection bias possible; generalizability to larger or more complex tumors uncertain.
Future Directions: Prospective multicenter comparisons versus conventional cervical approaches to quantify differences in nerve outcomes, cosmesis, and recurrence.
BACKGROUND: This study evaluates the outcomes of intracapsular enucleation using the retroauricular hairline incision (RAHI) approach for treating cervical vagal schwannomas. METHODS: A longitudinal study was conducted on patients with cervical vagal schwannomas. Eleven patients who underwent RAHI-based enucleation were included. Preoperative imaging was performed using contrast-enhanced MRI. Postoperative evaluations assessed pain, neurological function, cosmetic outcomes, voice, and swallowing functions. RESULTS: Eleven patients underwent surgery. The median tumor size was 4.6 cm. The median operation time was 42 min, with minimal bleeding. Common complications were earlobe numbness (45%) and temporary vocal cord paralysis (27%), which were resolved within a year. Cosmetic satisfaction was high, with median VAS scores of nine for scars and 10 for facial deformities. No significant dysphagia was found. No recurrences were observed over a median follow-up of 79 months. CONCLUSIONS: Intracapsular enucleation using the RAHI approach is a safe and effective method for treating cervical vagal schwannomas.